Uhlig, Christopher http://orcid.org/0000-0001-6361-8551
Rössel, Thomas
Denz, Axel
Seifert, Sven
Koch, Thea
Heller, Axel Rüdiger
Funding for this research was provided by:
Fresenius Kabi Deutschland AG (Please see Funding declaration)
Technische Universität Dresden (DE)/SLUB (IN-1502335)
Article History
Received: 13 May 2019
Accepted: 6 August 2019
First Online: 17 August 2019
Ethics approval and consent to participate
: The present trial was approved by the Bundesinstitut für Arzneimittelsicherheit und Medizinprodukte (BfArM, GZ 61–3910-4031476), and the local Institutional Review Board “Ethikkommission an der Technischen Universität Dresden” (AZ 193112005). Written informed consent was obtained from all participants prior to trial enrollment.
: Not applicable.
: ARH received study grants by Fresenius Kabi Deutschland AG, Bad Homburg, Germany and speaker honoraria by CSL- Behring, Marburg, Germany. TK received speaker honoraria from Fresenius Kabi Deutschland AG, Bad Homburg, Germany. CU, TR, AD, and SS declare that they have no competing interests.